Samsung Medical Center
Korea's highest-ranked cancer hospital, a major site for Asian ADC and lung cancer trials.
Samsung Comprehensive Cancer Center; leading enroller in global NSCLC, gastric, and breast ADC trials; proton therapy centre.
- Lung cancer trials
- Gastric cancer
- Proton therapy
A liver cancer oncologist who has been on the steering group of several global HCC trials with strong Asian enrolment.
A gastric cancer trialist who pioneered biomarker-driven umbrella trials in Korea and helped bring HER2 and Claudin 18.2 agents to Asian patients.
Myung-Ju Ahn is one of Asia's most prolific lung cancer trialists, a steady presence on the steering committees of the EGFR, ALK, and immunotherapy trials that set today's standards.
A senior gastric cancer oncologist whose adjuvant and perioperative trials in Korea helped define post-gastrectomy chemotherapy.
Built the genome institute behind Samsung Medical Center's precision oncology programme and its single-cell studies of tumours.
Leads breast medical oncology at Samsung Medical Center and has driven Korean participation in the HER2 and CDK4/6 trials that changed practice.